The Irvine, Calif.-based medical device company said Abate, 60, will stay on as CFO while the search goes on. Edwards hired Peter Crist of Crist/Kolder Associates to assist in the quest, according to a press release.
"Tom has had a very productive 31-year career with our company, and I want to thank him for his many significant contributions to our success," chairman & CEO Michael Mussallem said in prepared remarks. "Tom played an important role in establishing Edwards as a standalone company following our spinoff from Baxter Healthcare Corporation in 2000. He has been a valuable business partner and has been instrumental in helping us adapt to an evolving financial landscape, while also positioning the company for the future. His dedication to Edwards has been exemplary, and we look forward to his continued leadership through this transition."
Abate has been Edwards’ finance head since 2006, after a 6-year stint as vice president & controller. He was with Edwards’ corporate parent, Baxter, until the Edwards spinout in 2000, according to the release.
Ex-Boston Scientific exec rejoins laws firm
Nena Bains, formely vice president of intellectual property at Boston Scientific (NYSE:BSX), rejoined the law firm Kilpatrick Townsend & Stockton, which is looking to expand its medical device practice.
Sonoma adds 3 new executives
Sonoma Orthopedic hired 3 new personnel to its executive team. Victoria Good is the new director of clinical affairs, Alex Winber is the new VP of marketing and Kyle Lappin is the new director of R&D. All 3 will be working from the company’s headquarters outside Chicago.
Jones Day pulls in a new partner from Greenberg Traurig
Former Greenberg Traurig litigator Jose Isasi II joined Jones Day as a partner. Isasi has pharmaceutical and medical device product liability experience, and he had served at Greenberg since 2006.
Delcath trims titles, replaces global health veep
Delcath Systems (NSDQ:DCTH) named Jennifer Simpson its new VP of global health after the departure of Agustin Gago in April. The company also eliminated its executive VP of global sales and executive VP of business development roles.
Covidien director Connors retires
This week, Covidien (NYSE:COV) board member John Connors Jr. announced his retirement. He will stay on through the summer and will depart at the end of the fiscal year in September.